Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 0 | 37 | 215 | 87 | 16 |
| Cost of Goods | N/A | 0 | 287 | 392 | 18 |
| Gross Profit | N/A | 37 | -72 | -305 | -2 |
| Operating Expenses | 4,454 | 4,512 | 5,232 | 10,406 | 6,684 |
| Operating Income | -4,454 | -4,475 | -5,017 | -10,319 | -6,668 |
| Interest Expense | 183 | 182 | 46 | 0 | 0 |
| Other Income | -370 | 1,163 | 2,764 | 2,227 | 5,261 |
| Pre-tax Income | -5,007 | -3,494 | -2,299 | -8,092 | -1,407 |
| Net Income Continuous | -5,007 | -3,494 | -2,299 | -8,092 | -1,407 |
| Net Income | $-5,007 | $-3,494 | $-2,299 | $-8,092 | $-1,407 |
| EPS Basic Total Ops | -3.00 | -1.15 | -0.80 | -2.75 | -0.50 |
| EPS Basic Continuous Ops | -1.70 | -1.19 | -0.79 | -2.77 | -0.48 |
| EPS Diluted Total Ops | -3.00 | -1.20 | -0.80 | -2.75 | -1.15 |
| EPS Diluted Continuous Ops | -1.70 | -1.19 | -0.79 | -2.77 | -0.48 |
| EBITDA(a) | $-4,363 | $-4,387 | $-4,932 | $-10,145 | $-6,451 |